Data / Form D filings / ROC Holdings SPV II, LP
ROC Holdings SPV II, LP: Form D filing
ROC Holdings SPV II, LP, a biotechnology company in Washington, DC, filed a Form D with the SEC in 2025. The latest, on August 21, 2025, reports $3.7 million sold of an offering with no set size to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1630 COLUMBIA ROAD NW, APT. 418, Washington, DC, 20009
- Phone
- (917) 912-2289
- Industry
- Biotechnology
- Entity type
- Limited Partnership
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b), Investment Company Act section 3(c), section 3(c)(7)
- SEC identifier (CIK)
- 2082735
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | New notice | Indefinite | $3,650,000 | 16 | May 15, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Dahlman | Director | |
| Matthew Smith | Director |
Other biotechnology companies in District of Columbia that filed recently
- OptoVista Holdings, LLC $3.7 million · Sep 25, 2026
Every Form D from the week of Aug 18, 2025 · All recent filings in District of Columbia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ROC Holdings SPV II, LP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.